ASSET terminates GMO, Macquarie mandates, seeks to insource rebalancing

ASSET Super has terminated a $45 million Australian equities mandate with GMO, and made an appointment aimed at allowing it to insource its passive rebalancing of portfolios.

The money that ASSET previously allocated to GMO’s core momentum Australian equities fund has been parceled out among Australian equities vehicles run by the following managers: Schroder Investment Management ($20 million), Quest Asset Partners ($15 million) and Challenger Financial Services ($10 million). “It’s a continuation of our strategy to get as much value as we can for members…We decided [GMO] weren’t delivering what we required,” John Paul, ASSET chief executive officer, said. The $1.6 billion industry fund, which uses Intech as its asset consultant, also took a $100 million cash mandate away from Macquarie Bank in May, directing $55 million of the money to ING Investment Management and $45 million to Perpetual Investments. Meanwhile, the fund last month hired Vijay Vittal, an accountant who previously worked at Citistreet, to monitor ASSET’s weekly unit prices and, in time, take passive rebalancing duties from National Custodian Services, the fund’s custodian.

, , , , , , , , , , ,

Leave a Comment

‘Bang, fizzle, pop’: AustralianSuper CIO laments late tilt to AI

The outgoing chief investment officer of AustralianSuper Mark Delaney said one of the biggest regrets he will have as he leaves the $410 billion fund is not going overweight on the AI and digital thematic in public markets sooner, as the nation’s most powerful allocator reflects on the investment case of the technology sector in the superannuation summit in New York last week.

Sort content by